Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 38,414 shares at $20.32 ($777K) on 2020-12-09, disclosed to the SEC on 2020-12-10.
Open-market sale of $777k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.19 | 13,161 | $266K | 34.2% |
| 2 | $20.19 | 13,161 | $266K | 34.2% |
| 3 | $20.32 | 5,773 | $117K | 15.1% |
| 4 | $20.32 | 5,773 | $117K | 15.1% |
| 5 | $20.00 | 546 | $11K | 1.4% |
| Total | $20.23 avg | 38,414 |
| $777K |
| 100% |
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |
| GTHX | SELL | 2018-12-04 | $782K | — | Filing → |